FIBROCOR THERAPEUTICS
Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis.The company has already identified a lead program and will partner with Evotec to develop novel molecules .
FIBROCOR THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.fibrocortherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
2.8 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx Euro
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bicara Therapeutics
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Current Employees Featured
Founder
Investors List
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners investment in Seed Round - Fibrocor Therapeutics
Official Site Inspections
http://www.fibrocortherapeutics.com Semrush global rank: 5.24 M Semrush visits lastest month: 1.56 K
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Fibrocor Therapeutics"
Fibrocor Therapeutics - LinkedIn
Fibrocor Therapeutics | 755 followers on LinkedIn. Targeting Fibrosis Through the Lens of Disease Progression | We develop clinically driven, first-in-class, tissue-specific therapeutics …See details»
Fibrocor Therapeutics Inc. - VentureRadar
Nov 8, 2024 "Fibrocor Therapeutics is dedicated to developing novel medicines to combat diseases of fibrosis, which account for nearly 45% of deaths in the industrialized world. …See details»
Fibrocor Therapeutics Inc. · 661 University Ave, Suite 1300, Toronto ...
Fibrocor Therapeutics Inc. is a federal corporation in Toronto, Ontario incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) …See details»
Fibrocor Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Fibrocor Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Overview, News & Similar companies - ZoomInfo.com
Jan 6, 2021 View Fibrocor Therapeutics (www.fibrocortherapeutics.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Fibrocor Therapeutics | VentureRadar
Fibrocor Therapeutics is a biotech company focused on developing innovative medicines to treat fibrosis-related diseases. Leveraging a patient-derived target discovery platform and one of …See details»
Fibrocor Therapeutics - Craft
See insights on Fibrocor Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Fibrocor Therapeutics L.P. - VentureRadar
Fibrocor Therapeutics, founded in 2017 with an exclusive license to tissue biobanks of kidney, liver and lung biopsies, differentiated by its best-in-class longitudinal medical record data. …See details»
Fibrocor Therapeutics LP:Company Profile & Technical Research ...
Fibrocor Therapeutics is a company that provides Kidney fibrosis, Health care, Pharmacy and Therapeutics and more. Fibrocor Therapeutics is headquartered in Canada Ontario. Fibrocor …See details»
Fibrocor Therapeutics - Crunchbase Company Profile
Fibrocor Therapeutics focuses on developing disease modifying therapeutics in fibrosis.See details»
Fibrocor Therapeutics Information - RocketReach
Fibrocor Therapeutics is a Biotechnology Research, Business Services General, and Business Services company located in Toronto, Ontario with $6 million in revenue and 11 employees. …See details»
What You Need to Know About Fibrocor Therapeutics - BioSpace
Dec 6, 2017 Company Leadership Mark Steedman – Chief Executive Officer. Steedman is the Vice President of Business Development and Founder of Interface Biologics and a board …See details»
Fibrocor Therapeutics - VentureRadar
"Fibrocor Therapeutics is a biotech company focused on developing innovative medicines to treat fibrosis-related diseases. Leveraging a patient-derived target discovery platform and one of …See details»
Fibrocor Therapeutics Company Profile | Management and
Find contact information for Fibrocor Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Fibrocor Therapeutics's email format.See details»
Fibrocor Therapeutics - Products, Competitors, Financials, …
About Fibrocor Therapeutics Fibrocor Therapeutics focuses on developing novel medicines for the treatment of fibrotic diseases within the healthcare sector. The company's main offerings …See details»
FIBROCOR THERAPEUTICS INC. - website, address, tel. & director …
Date of Incorporation Mar 09 2021 Record Status:Delinquent State Of Incorporation: CANADA Company Type & Class: Profit Category: Regular Corporation Date of Expiration: Mar 31 2022 …See details»
Treating Diseases Like PF Focus of Newly Formed Fibrocor …
Jan 25, 2017 Fibrocor, formed by Evotec and MaRS Innovation, will focus on developing therapies that could prevent or reverse the course of fibrosis.See details»
Fibrocor Therapeutics LP:Company Profile & Technical Research ...
Fibrocor Therapeutics is a company that provides Kidney fibrosis, Health care, Pharmacy and Therapeutics and more. Fibrocor Therapeutics is headquartered in Canada Ontario. Fibrocor …See details»
Fibrocor Therapeutics L.P. | Insights
Mar 12, 2024 Bridge Biotherapeutics Inc. has reached a global licensing out and collaboration agreement with Boehringer Ingelheim GmbH for the South Korean biotech’s early clinical …See details»
Fibrocor and Galapagos sign expanded collaboration in
Jan 15, 2020 Fibrocor is a privately held Canadian company specializing in the development of tissue-specific therapeutics to treat fibrotic diseases of the kidney, liver, lung and other organs. …See details»